Effect of fibroblasts in breast cancer microenvironment on expression of TIGAR and Bcl-2 of breast cancer cells
10.3969/j.issn.1000-484X.2018.02.004
- VernacularTitle:乳腺癌微环境成纤维细胞对乳腺癌细胞表达TIGAR和Bcl-2的影响
- Author:
Sai LIU
1
;
Shao-Fen CHEN
;
Wen-Lin LI
;
Xiao-Yu SHI
Author Information
1. 南昌大学医学部基础医学院
- Keywords:
Fibroblast;
Breast cancer;
TIGAR;
Bcl-2
- From:
Chinese Journal of Immunology
2018;34(2):177-182
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To investigate the effect of fibroblasts in breast cancer microenvironment on the expression of TIGAR and Bcl-2 in breast cancer cells and their effect on breast cancer growth.Methods: In vitro experiments,the co-cultured model of human breast cancer cell line MDA-MB-231 with human fibroblast line CCC-ESF-1 was established.The effect of fibroblasts on the expression of TIGAR and Bcl-2 in breast cancer cells was tested with reverse transcription quantitative polymerase chain reaction(RT-qPCR) and Western blot.Annexin V flow cytometry and caspase-3 activity assay were employed to detect the apoptosis of breast cancer cells.In vivo experiments,human breast cancer transplanted tumor model in nude mice was established and the tumor volume of nude mice was meas-ured.Immunohistochemistry was used to detect TIGAR and Bcl-2 expression in the transplanted tumor tissues of nude mice.Results:The results showed that the co-cultured fibroblasts could up-regulate the expression of TIGAR and Bcl-2 in MDA-MB-231 cells and inhibited the apoptosis of MDA-MB-231 cells in vitro.The fibroblasts implanted with breast cancer cells could up-regulate TIGAR and Bcl-2 expression in breast cancer tissues of tumor-bearing nude mice in vivo,whereas highly expressed TIGAR and Bcl-2 accelerated the tumor growth of tumor-bearing nude mice.Conclusion:The fibroblasts in breast cancer microenvironment up-regulate the expression of TIGAR and Bcl-2 in breast cancer cells co-cultured with fibroblasts.Highly expressed TIGAR and Bcl-2 inhibit the apoptosis of breast cancer cells and promote the growth of breast cancer.
